Predictive biomarkers of response to bacillus Calmette‐Guérin immunotherapy and bacillus Calmette‐Guérin failure for non‐muscle invasive bladder cancer
Author:
Affiliation:
1. Department of Urology National University Hospital Singapore
2. Department of Internal Medicine Singapore General Hospital Singapore
Publisher
Wiley
Subject
Urology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14921
Reference64 articles.
1. European Association of Urology Guidelines on non‐muscle‐invasive bladder cancer (Ta, T1, and carcinoma in situ);Babjuk M;Eur. Urol.,2021
2. Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
3. Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
4. EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
5. Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Immune-checkpoint gene expression and BCG response in non-muscle invasive bladder cancer;Translational Oncology;2024-08
2. Tumor Biomarkers for Bacillus Calmette-Guérin Response: What We Get Is Not What We Want;European Urology Focus;2023-07
3. The cuproptosis-associated 11 gene signature as a predictor for outcomes and response to Bacillus Calmette-Guerin and immune checkpoint inhibitor therapies in bladder carcinoma;Frontiers in Immunology;2023-05-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3